Back to Search
Start Over
Transferrin and HFE genes interact in Alzheimer's disease risk: the Epistasis Project.
- Source :
-
Neurobiology of aging [Neurobiol Aging] 2012 Jan; Vol. 33 (1), pp. 202.e1-13. Date of Electronic Publication: 2010 Sep 02. - Publication Year :
- 2012
-
Abstract
- Iron overload may contribute to the risk of Alzheimer's disease (AD). In the Epistasis Project, with 1757 cases of AD and 6295 controls, we studied 4 variants in 2 genes of iron metabolism: hemochromatosis (HFE) C282Y and H63D, and transferrin (TF) C2 and -2G/A. We replicated the reported interaction between HFE 282Y and TF C2 in the risk of AD: synergy factor, 1.75 (95% confidence interval, 1.1-2.8, p = 0.02) in Northern Europeans. The synergy factor was 3.1 (1.4-6.9; 0.007) in subjects with the APOEε4 allele. We found another interaction, between HFE 63HH and TF -2AA, markedly modified by age. Both interactions were found mainly or only in Northern Europeans. The interaction between HFE 282Y and TF C2 has now been replicated twice, in altogether 2313 cases of AD and 7065 controls, and has also been associated with increased iron load. We therefore suggest that iron overload may be a causative factor in the development of AD. Treatment for iron overload might thus be protective in some cases.<br /> (Copyright © 2012 Elsevier Inc. All rights reserved.)
- Subjects :
- Aged
Aged, 80 and over
Aging genetics
Alzheimer Disease prevention & control
Apolipoprotein E4 genetics
Female
Hemochromatosis Protein
Humans
Iron Chelating Agents therapeutic use
Iron Overload therapy
Male
Oxidative Stress genetics
Risk
Alzheimer Disease etiology
Epistasis, Genetic genetics
Histocompatibility Antigens Class I genetics
Iron Overload complications
Iron Overload genetics
Membrane Proteins genetics
Transferrin genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1558-1497
- Volume :
- 33
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Neurobiology of aging
- Publication Type :
- Academic Journal
- Accession number :
- 20817350
- Full Text :
- https://doi.org/10.1016/j.neurobiolaging.2010.07.018